Skip to main content
$34.05 +0.19 (+0.56%)
Market Cap
$310.29M
Shares
9.16M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$103.12M +19%
FY2025 Revenue FY2010–FY2025
Net Income
-$37.56M -288.7%
FY2025 Net Income FY2010–FY2025
Gross Margin
92.71% +2.1pp
FY2025 Gross Margin FY2010–FY2025
Operating Margin
7.08% +5.6pp
FY2025 Operating Margin FY2010–FY2025
Diluted EPS
-$4.36 -282.5%
FY2025 Diluted EPS FY2016–FY2025
Operating Cash Flow
$6.79M +28634.4%
FY2025 Operating Cash Flow FY2010–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
$116M – $121M $107.48M $103.12M $86.67M $64.99M $45.84M $24.14M $15.59M $11.77M $5.84M $6.3M $5.51M $3.37M $2.63M $1.73M $1.17M $2.21M $910.42K
$7.61M $7.52M $8.14M $7.85M $6.36M $2.31M $1.62M $1.21M $507.42K $806.04K $943.58K $891.97K $803.63K $792.77K $798.53K $799.63K $538.27K
$99.87M $95.6M $78.53M $57.14M $39.48M $21.83M $13.97M $10.56M $5.33M $5.5M $4.56M $2.48M $1.83M $933.62K $375.01K $1.41M $372.15K
92.71% 90.61% 87.92% 86.12% 90.43% 89.63% 89.72% 91.31% 87.22% 82.87% 73.55% 69.47% 54.08% 31.96% 63.81% 40.88%
$4.88M $5.07M $2.83M $4.13M $3.37M $558.7K $40.19K
$62.01M $56.29M
$16.71M $15.39M $28.05M $18.67M $13.07M $5.74M $5.28M $3.95M $3.38M $3.84M $3.81M $5.71M $2.23M
$81.47M $78.72M $71.67M $56.99M $45.98M $28.05M $2.75M $2.34M
$2.38M $2.49M $2.59M $3.22M $1.96M $376.4K $223.53K $90.01K
$3.41M $3.95M $4.92M $3.68M $2.37M $596.98K $291.37K $119.95K $83.89K $80.65K $60.88K $60.03K $56.45K $51.66K $61.17K $470.62K $471.76K
$90.75M $88.29M $77.27M $61.35M $52M $29.21M $19M $13.3M $5.83M $5.38M $4.84M $3.45M
$9.13M $7.3M $1.26M -$4.22M -$12.52M -$7.38M -$5.03M -$2.74M -$501.86K $120.44K -$272.13K -$964.98K -$5.01M -$2.48M
7.08% 1.45% -6.49% -27.3% -30.55% -32.3% -23.29% -8.6% 1.91% -4.94% -28.62% -226.95% -271.94%
$12.53M $11.25M $6.18M -$540.13K -$10.15M -$6.78M -$4.74M -$2.62M -$417.97K $201.09K -$211.25K -$904.95K -$4.54M -$2M
$7.24M $6.76M $3.13M $475.78K $284.75K $711 $11.53K $105.92K $86.59K $126.83K $174.49K $176.89K $293.9K $1.73M $286.62K -$262.34K -$801.78K
-$22.08K $125 $21 $20 $103 $0 $166.54K $277.77K $157.72K
-$8.5M -$7.7M -$3.2M -$224.75K -$1.42M -$617.64K $589.47K -$95.72K -$98.71K $210.86K -$143.61K -$375.47K
-$1.27M -$952.47K -$90.01K -$379.63K -$616.93K -$9951 $0
-$393.12K -$1.89M -$4.44M -$13.94M -$7.99M -$1.85M -$12.74M -$6.64M
$48.38K -$5.84M $0 $0 $0 $0 $0 $0 $0 $0
-$33.57M -$37.56M -$9.66M -$4.3M -$7.94M -$7.92M -$4.45M -$2.81M -$600.57K $331.31K -$415.75K -$1.34M -$2.28M -$4.15M -$1.85M -$12.74M -$6.64M
-36.43% -11.15% -6.62% -17.31% -32.81% -28.52% -23.92% -10.29% 5.25% -7.55% -39.75% -86.54% -240.27% -157.24% -576.59% -729.53%
-$5589 -$5441 -$247.35K -$136.71K -$154.83K -$71.88K -$88.71K -$21.69K
-$11.39M -$7.92M -$4.36M -$731.83K $192.3K -$677.46K -$1.61M -$2.51M -$4.15M
USD/shares -$4.36 -$1.14 -$0.52 -$1.00 -$1.08 -$0.76 -$1.32 $0.00 $0.00 -$0.01
USD/shares -$4.36 -$1.14 -$0.52 -$1.00 -$0.76 -$1.32 $0.00 $0.00 -$0.01
shares 8.62M 8.48M 8.28M 7.91M 7.34M 5.73M 2.13M 217.16M 111.38M 108.6M 106.7M 87.94M 77.71M 62.84M 54.7M 35.82M
shares 8.62M 8.48M 8.28M 7.91M 7.34M 5.73M 2.13M 217.16M 208.65M 108.6M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 1.28×
EV/EBIT
P/E (TTM)
Peer median 29.06×

Peer medians compare against the 21 similar-size Medical Instruments & Supplies companies (of 48 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2024 FY2023
Sanara Surgical $86,672,425 $64,987,112
THP $2,730

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Soft Tissue Repair Products $91,347,493 $76,125,012 $54,836,410 $41,653,954
Bone Fusion Products $11,770,489 $10,547,413 $9,952,432 $3,987,891
Product Sales Revenue $15,385,976
Royalty Revenue $201,000 $201,000
Sanara Legacy Product Sales $23,942,919
Royalty $201,000 $201,000
Key facts CIK 714256 CUSIP 79957L100 13F (30d) 14 filings 14 filers Visit website Investor relations